Cas:56442-18-3 4-[(3,4-dichlorophenyl)methoxy]benzoic acid manufacturer & supplier

Chemical Name:4-[(3,4-dichlorophenyl)methoxy]benzoic acid

CAS.NO:56442-18-3

Synonyms:4-[(3,4-dichlorobenzyl)oxy]benzoic acid;4-(3,4-Dichlorbenzyloxy)-benzoesaeure;dichlorobenzyloxybenzenecarboxylicacid

Molecular Formula:C₁₄H₁₀Cl₂O₃

Molecular Weight:297.13300

HS Code:2918990090

Physical and Chemical Properties:

Melting point:210-214ºC

Boiling point:450.6ºC at 760mmHg

Density:1.411g/cm3

Index of Refraction:1.621

PSA:46.53000

Exact Mass:296.00100

LogP:4.27060

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[(3,4-dichlorobenzyl)oxy]benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dichlorobenzyloxybenzenecarboxylicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(3,4-Dichlorbenzyloxy)-benzoesaeure Use and application,dichlorobenzyloxybenzenecarboxylicacid technical grade,usp/ep/jp grade.

Related News: Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. 4-[(3,4-dichlorophenyl)methoxy]benzoic acid manufacturer The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. 4-[(3,4-dichlorophenyl)methoxy]benzoic acid supplier The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. 4-[(3,4-dichlorophenyl)methoxy]benzoic acid vendor Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. 4-[(3,4-dichlorophenyl)methoxy]benzoic acid factory With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.